{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:50:19Z","timestamp":1776495019198,"version":"3.51.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Epidemiological and observational studies demonstrate a comorbid relationship between hypothyroidism and atherosclerotic cardiovascular disease (ASCVD). The nature and direction of this causal relationship, however, remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aims to elucidate the causal relationship between hypothyroidism and ASCVD using a bidirectional Mendelian randomization approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Single nucleotide polymorphisms (SNPs) associated with hypothyroidism were identified and selected as genetic instrumental variables from aggregated data of genome-wide association studies (GWAS). The outcome of interest, ASCVD, included seven conditions: coronary artery disease (CAD), angina pectoris (AP), myocardial infarction (MI), ischemic stroke (IS), and subtypes IS-large artery atherosclerosis (IS-LAA), IS-small vessels (IS-SV), and peripheral artery disease (PAD). MR analysis employed multiple methods\u2014chiefly inverse variance weighting (IVW), along with MR Egger, weighted median, and weighted mode\u2014to assess causality. Cochrane's <jats:italic>Q<\/jats:italic> test was utilized to evaluate heterogeneity in the MR findings. Causal association reliability was assessed using the MR-Egger intercept, MR-PRESSO tests, and leave-one-out analysis. Reverse MR analysis ensued if forward MR identified a positive exposure-outcome association. Moreover, the DAVID database facilitated GO functional and KEGG pathway enrichment analyses of neighboring genes to instrumental variables, exploring potential disease mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>GWAS pooled data yielded 122 SNPs as potential instrumental variables for hypothyroidism. Forward MR analysis, using the IVW method, indicated hypothyroidism as a risk factor for CAD (OR\u2009=\u20092.34, 95% CI\u2009=\u20091.39\u20133.94, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), AP (OR\u2009=\u20092.01, 95% CI\u2009=\u20091.28\u20133.16, <jats:italic>P<\/jats:italic>\u2009=\u20090.002), MI (OR\u2009=\u20091.02, 95% CI\u2009=\u20091.01\u20131.04, <jats:italic>P<\/jats:italic>\u2009=\u20090.004), and IS-SV (OR\u2009=\u20096.92, 95% CI\u2009=\u20092.45\u201319.55, <jats:italic>P<\/jats:italic>\u2009&amp;lt;\u20090.001). However, no significant link was found between hypothyroidism and the remaining three diseases, with sensitivity analysis reinforcing result robustness. In contrast, reverse MR analysis did not corroborate a causal link from ASCVD to hypothyroidism. The R package identified 83 neighboring genes as instrumental variables. GO enrichment analysis via the DAVID database yielded 53 entries, predominantly involving cAMP catabolic processes, protein binding, and signal transduction. KEGG analysis identified 31 pathways, notably those related to Th1\/Th2 and Th17 cell differentiation, and Herpes simplex virus 1 infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The marked association between hypothyroidism and CAD, AP, MI, and IS suggests that thyroid function assessment could be integral to preventing and diagnosing specific ASCVD types. This underscores the need for individuals with hypothyroidism to be proactive regarding ASCVD risk factors. A balanced Th1\/Th2 and Th17\/Treg ratio may offer a novel strategy in preventing CAD and enhancing the prognosis for hypothyroid patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1402359","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T04:54:05Z","timestamp":1729745645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Causal relationship between hypothyroidism and coronary atherosclerotic cardiovascular disease: a bidirectional two-sample Mendelian randomization"],"prefix":"10.3389","volume":"11","author":[{"given":"Jiarui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Likun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1714\/4191.41785","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"25","author":"Byrne","year":"2024","journal-title":"G Ital Cardiol (Rome)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1016\/j.jacc.2021.05.006","article-title":"Multi-ethnic study of atherosclerosis (MESA)","volume":"77","author":"Blaha","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.amjmed.2021.07.027","article-title":"Ischemic stroke","volume":"134","author":"Feske","year":"2021","journal-title":"Am J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-444-64034-5.00019-5","article-title":"Hemorrhagic stroke","volume":"176","author":"Monta\u00f1o","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/ije\/dyx259","article-title":"Cohort profile: the epidemiology of chronic diseases and multimorbidity. The EpiChron cohort study","volume":"47","author":"Prados-Torres","year":"2018","journal-title":"Int J Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.2010.0429","article-title":"Thyroid hormones as modulators of immune activities at the cellular level","volume":"21","author":"De Vito","year":"2011","journal-title":"Thyroid"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.3390\/ijms20143377","article-title":"Protective effects of euthyroidism restoration on mitochondria function and quality control in cardiac pathophysiology","volume":"20","author":"Forini","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism: a review","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s12020-022-02982-4","article-title":"Thyroid disorders and cardiovascular manifestations: an update","volume":"75","author":"Paschou","year":"2022","journal-title":"Endocrine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/eurheartj\/ehv694","article-title":"Should we screen for hypothyroidism in patients with cardiovascular disease?","volume":"37","author":"Gencer","year":"2016","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.219655","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"afac256","DOI":"10.1093\/ageing\/afac256","article-title":"Frailty and cardiometabolic diseases a bidirectional Mendelian randomization study","volume":"51","author":"Zhu","year":"2022","journal-title":"Age Ageing"},{"key":"B19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/gepi.22207","article-title":"Implementing MR-PRESSO and GCTA-GSMR for pleiotropy assessment in Mendelian randomization studies from a practitioner's perspective","volume":"43","author":"Ong","year":"2019","journal-title":"Genet Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/STROKEAHA.120.031710","article-title":"Modifiable lifestyle factors and risk of stroke","volume":"52","author":"Harshfield","year":"2021","journal-title":"stroke"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","article-title":"Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study","volume":"21","author":"Long","year":"2023","journal-title":"BMC Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","article-title":"Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome","volume":"43","author":"Burgess","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1113\/jphysiol.2005.098426","article-title":"Excitation-transcription coupling in smooth muscle","volume":"570","author":"Barlow","year":"2006","journal-title":"J Physiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e24803","DOI":"10.1002\/jcla.24803","article-title":"Serum brain-derived neurotrophic factor in coronary heart disease: correlation with the T helper (Th)1\/Th2 ratio. T:h17.\/regulatory T (Treg) ratio, and major adverse cardiovascular events","volume":"37","author":"Huo","year":"2023","journal-title":"J Clin Lab Anal"},{"key":"B27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-017-0777-9","article-title":"What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants","volume":"15","author":"Ning","year":"2017","journal-title":"BMC Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"l2006","DOI":"10.1136\/bmj.l2006","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"Br Med J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/eurheartj\/ehv737","article-title":"Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention","volume":"37","author":"Zhang","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1402359\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T04:54:06Z","timestamp":1729745646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1402359\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2024.1402359"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1402359","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"article-number":"1402359"}}